Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

1.70
Delayed Data
As of Mar 27
 +0.30 / +21.43%
Today’s Change
0.94
Today|||52-Week Range
8.90
-24.44%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close1.40
Today’s open1.50
Day’s range1.45 - 1.75
Volume3,937,589
Average volume (3 months)887,965
Market cap$90.0M
Dividend yield--
Data as of 03/27/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+9.03%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book1.60

Competitors

 Today’s
change
Today’s
% change
EIGREiger BioPharmaceuti...+0.40+3.85%
NAVBNavidea Biopharmaceu...-0.01-1.72%
ADMPAdamis Pharmaceutica...-0.05-1.16%
SNSSSunesis Pharmaceutic...+0.09+2.19%
Data as of 03/27/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs